 |
 |

Clinical Evaluation of Digitalization in Glaucoma
JOSÉ D. PECZON, MD
Arch Ophthalmol. 1964;71(4):500-504.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
According to Simon and Bonting, the cardiac glycoside digoxin administered in its usual dosage to patients having "congenital," "juvenile," and "chronic simple" glaucoma, caused a 45% decrease in aqueous formation, also a fall in intraocular pressure which averaged 14% in "chronic simple" glaucoma.1 When digoxin was administered in combination with acetazolamide, a 65% decrease in aqueous formation was reported, whereas acetazolamide alone caused a 50% decrease. Interference with aqueous formation and lowering of intraocular pressure by digoxin and other cardiac glycosides was thought to be brought about by inhibition of the enzyme Na-K-ATPase in the ciliary processes. According to these observations, the digitalis glycosides with their reasonably low toxicity and easy mode of administration seemed to have promise as an adjunct in the treatment of glaucoma. For further evaluation of practical usefulness and effectiveness, we have accordingly made a trial of digitalization with digoxin and other digitalis glycosides as
. . . [Full Text PDF of this Article]
Author Affiliations
Boston
Fellow in the Glaucoma Consultation Service, Massachusetts Eye and Ear Infirmary, Boston 14, Massachusetts.
Footnotes
Submitted for publication Sept 25, 1963.
This work was supported by grants from the Institute of Neurological Diseases and Blindness of the National Institute of Health, United States Public Health Service (Research Grant B-218), and by the Concordia Foundation, under the supervision of W. Morton Grant, MD.
Acknowledgment is due the several residents who participated in obtaining data: D. Weis, C. Beyers, L. Aiello, R. Houle, A. Kroll, D. Miller, R. Robb, T. Aaberg and R. Petersen.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|